New Zealand markets closed

Portage Biotech Inc. (PRTG)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2402-0.0125 (-4.95%)
At close: 04:00PM EDT
0.2400 -0.00 (-0.08%)
After hours: 04:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.75M
Enterprise value -313.79k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.15
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.00

Trading information

Stock price history

Beta (5Y monthly) 99.75
52-week change 3-93.22%
S&P500 52-week change 322.36%
52-week high 34.4000
52-week low 30.2000
50-day moving average 30.4876
200-day moving average 31.5557

Share statistics

Avg vol (3-month) 397.8k
Avg vol (10-day) 3250.37k
Shares outstanding 519.78M
Implied shares outstanding 619.78M
Float 810.21M
% held by insiders 138.82%
% held by institutions 111.61%
Shares short (15 Apr 2024) 48.38k
Short ratio (15 Apr 2024) 40.09
Short % of float (15 Apr 2024) 40.06%
Short % of shares outstanding (15 Apr 2024) 40.04%
Shares short (prior month 15 Mar 2024) 415.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 304 Jun 2020
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 304 Jun 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-9.13%
Return on equity (ttm)-145.19%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -18.93M
Net income avi to common (ttm)-144.9M
Diluted EPS (ttm)-8.5200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.34M
Total cash per share (mrq)0.27
Total debt (mrq)275k
Total debt/equity (mrq)0.88%
Current ratio (mrq)2.78
Book value per share (mrq)1.62

Cash flow statement

Operating cash flow (ttm)-15.86M
Levered free cash flow (ttm)-8.47M